Search

Issue
Title
Authors
Effects of ipragliflozin in patients with type 2 diabetes mellitus, arterial hypertension and left ventricular diastolic dysfunction in a short-term prospective study
Safronova S.S., Druk I.V., Kanunnikova O.I., Korennova O.Y., Podolnaya S.P., Klepatskaya T.Y., Kalinina I.D.
Intensification of diabetes therapy using insulin degludec. A series of atypical clinical cases
Smirnova E.Y.
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.G.
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.V.
Diabetes mellitus and new coronavirus infection: a look into the past; conclusions on prevention and treatment tactics for the future
Aramisova L.S., Zhurtova I.B., Gubachikova A.M.
Metabolic comorbidity of endometritis after caesarean section
Korobkov N.A., Bakulina N.V., Borovik N.V.
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Dukhareva O.V., Demidov N.A., Novikova M.S.
The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice
Koteshkova O.M., Dukhareva O.V., Demidov N.A., Antsiferov M.B.
Carbohydrate metabolism disorders and osteoporosis
Alekseeva N.S.
Analysis of anxiety-depressive states of patients with psoriasis and diabetes mellitus
Morzhanaeva M.A., Shchepkina E.V.
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
Shchukina E.V., Gromenkov V.D., Suprun Y.V., Mykhailichenko E.S., Beryozova E.V., Bagriy V.A., Golodnikov I.A.
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A.M., Markova T.N.
The many faces of vitamin D
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I.
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A.F., Lomonova T.V., Sharonova L.A.
Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus
Fedorchenko Y.L., Martynyuk M.V.
Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control
Biryukova E.V.
Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus
Mkrtumyan A.M., Podachina S.V., Sviridova M.I.
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
Koteshkova O.M., Molina L.P.
Kombinirovannaya tsitostaticheskaya i angioprotektivnaya terapiya bol'nykh psoriazom
Bakulev A.L., Utts S.R., Shtoda Y.M.
Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'
Pashentseva A.V., Verbovoy A.F.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.V.
FAKTORY RISKA RAZVITIYa OSTEOPOROZA
Akimova D.V.
Farmakoterapiya diabeticheskoy nevropatii: chto eshche krome kontrolya glikemii?
Biryukova E.V., Danilova T.B.
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.A.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M.B., Schemthaner G., Ametov A.S.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Dorofeeva L.G.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A.S., Brashchenkova A.V.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A.F., Vorozhtsova E.I., Orlova T.N.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N.A., Prudnikova M.A., Chernikova N.A., Prudnikova M.A.
OSTEOPOROZ: TOChKA ZRENIYa ENDOKRINOLOGA
Biryukova E.V.
ROLE OF GLYCATION END-PRODUCTS BLOCKERS IN THE DEVELOPMENT OF NEUROLOGIC COMPLICATIONS OF DIABETES MELLITUS
Podachina S.V., Podachina S.V.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Verification of the class of carbohydrate metabolism disorders in patients with hyperglycemia first detected on the background of acute coronary syndrome
Golitsyna T.Y., Golitsina T.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O.M., Smirin V.I., Ivashkin V.T., Drapkina O.M., Smirin V.I., Ivaschkin V.T.
Blood lipid profile in patients with obesity and type 2 diabetes mellitus and without type 2 diabetes mellitus before and after bariatric surgery
Mozgunova V.S., Volkova A.R., Semikova G.V., Khalimov Y.S., Vasilevsky D.I., Balandov S.G., Anisimova K.A.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
Kurnikova I.A., Chekalina M.S., Ualikhanova A.U.
Deintensification of insulin therapy in elderly patients with type 2 diabetes mellitus: impact on glycemic control and risk of hypoglycemia
Glinkina I.V., Oderiy A.V., Galkina A.P., Berdygylydzhova G.S., Fadeev V.V.
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study
Farmanov A.G., Bublik E.V., Vinogradskaya O.I., Udovichenko O.V., Zilov A.V., Ryzhkova E.G., Egorov V.I., Fadeev V.V., Deunezheva S.M., Zhivov A.V., Tobianskaya I.E.
Comparative characteristics of the incidence of various endocrinopathies in cancer patients receiving treatment with immune checkpoint inhibitors
Zhurtova I.B., Aramisova L.S., Abdul Moati H.A., Arkhestova D.R., Khachmakhova E.Z.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A.G., Bagriy A.E., Prikolota A.V., Prikolota O.A., Mikhailichenko E.S., Golodnikov I.A., Bagriy O.N.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V.I., Shatalova O.V., Klykova M.S., Stetsky N.P.
Glucometer with a mobile application as a system for remote control of diabetes
Koteshkova O.M., Dukhareva O.V., Demidov N.A., Antsiferov M.B., Golubeva Y.V.
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N.A., Martirosyan N.S., Valeeva F.V.
Obesity: an invisible disease
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I., Lomonova T.V.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N.A., Knyshenko O.A., Ivanova L.P.
Gestational diabetes mellitus: prevention of reproductive loss
Glavnova O.B., Shelygin M.S., Salukhova A.V.
Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus
Demicheva T.P.
Modern topical treatment of psoriasis in diabetic patients
Lykova S.G., Nemchaninova O.B., Svechnikova E.V., Morzhanayeva M.A.
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
Ametov A.S., Tertychnaya E.A.
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
Markova T.N.
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
Antsiferov M.B., Kvasnikov B.B.
Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus
Sorokina Y.A., Zanozin A.V., Zanozina O.V., Runov G.P.
Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage
Verbovoy A.F., Sharonova L.A., Burakshayev S.A., Kotelnikova E.V., Smirnova T.V.
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.Y.
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
Murkamilov I.T., Aytbaev K.A., Yusupov F.A.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M.B., Fadeev V.V., Morgunova T.B.
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
Badalyan O.L., Savenkov A.A.
Vozmozhnosti primeneniya insulina detemir pri lechenii sakharnogo diabeta u beremennykh: dokazannye preimushchestva i perspektivy ispol'zovaniya
Ruyatkina L.A., Sorokin M.Y.
Vliyanie Aktovegina na reparatsiyu khronicheskikh ran razlichnoy etiologii
Dibirov M.D., Gadzhimuradov R.U., Khalidov O.K., Kakubava M.R., Polyanskiy M.V.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.B.
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A.F., Sharonova L.A., Akhmerova R.I.
OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI
Arbatskaya N.Y.
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.A.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M.E., Derevyanchenko M.V.
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I.Y., Boeva V.V.
SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M.B., Galstyan G.R.
Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M.B., Ametov A.S., Zilov A.V., Antsiferov M.B., Ametov A.S., Zilov A.V.
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T.V., Nikonova T.V.
EVALUATION OF THE CLINICAL AND ECONOMIC EFFICIENCY OF PHARMACOTHERAPY OF DIABETIC POLYNEUROPATHY
Matveev N.V., Matveev N.V.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
PATHOGENETIC ASPECTS OF TREATMENT OF DISTAL PERIPHERAL POLYNEUROPATHY IN PATIENTS WITH DIABETES MELLITUS
Begma A.N., Begma I.V., Begma A.N., Begma I.V.
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y.V., Dedov I.I., Mayorov A.Y., Surkova E.V., Dedov I.I.
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T.Y., Demidova T.Y.
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K.K., Plotnikova O.A., Sharafetdinov K., Plotnikova O.
Model for predicting the severity and outcome of COVID-19 in patients with diabetes mellitus and obesity created based on artificial intelligence methods
Aramisova L.S., Zhurtova I.B., Akhubekova Z.A.
Combination therapy of a patient with chronic heart failure and type 2 diabetes mellitus: a clinical case of meldonium use
Statsenko M.E., Fabritskaya S.V., Derevyanchenko M.V.
Dynamics of the structure of non-insulin antihyperglycemic drug use in the treatment of type 2 diabetes mellitus (data from the Moscow segment Federal Diabetes Registry)
Demidov N.A.
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
Demicheva T.P.
Modern technologies in diabetes management
Koteshkova O.M., Antsiferov M.B., Antsiferova D.M., Demidov N.A.
Sulodexide: meta-analysis of the treatment of diabetic nephropathy and literature review
Novikova M.S., Koteshkova O.M., Antsiferov M.B.
The effectiveness of the use of natural mineral water “Donat” in the complex therapy of lipid and carbohydrate metabolism disorders
Mubarakshina O.A., Elizarova I.O., Cherenkova O.V.
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A.E., Prikolota O.A., Prikolota A.V., Mikhailichenko E.S., Golodnikov I.A., Bagriy O.N., Kotova K.A.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M.S., Koteshkova O.M., Antsiferov M.B.
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P.B., Baranov V.L.
Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)
Smirnova E.Y.
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N.А., Baranova N.I., Fedin A.V.
Cranial neuropathy as a complication of diabetes mellitus
Maksimova M.Y., Stepanchenko O.A.
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
Biryukova E.V., Solovyova I.V.
Insulin detemir and its place in the diabetes treatment: results of 15-year use
Girsh Y.V.
Apelin: biological and pathophysiological effects
Dolgikh Y.A., Verbovoy A.F.
Features of urine microflora in diabetic patients
Chikanova A.Y., Khamnuyeva L.Y., Karnoukhova O.G., Sudakova N.S., Tokareva N.P.
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.N.
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.B.
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.V.
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N.A., Zakharova S.K., Zav'yalov A.N.
101 - 200 of 333 Items << < 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"